DNMDP
DNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12) . DNMDP shows clear cell-selective cytotoxicity[1].
Product Specifications
CAS Number
328104-79-6
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dnmdp.html
Purity
99.46
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
[O-][N+](C1=CC(C(C(C)C2)=NNC2=O)=CC=C1N(CC)CC)=O
Molecular Formula
C15H20N4O3
Molecular Weight
304.34
References & Citations
[1]de Waal L, et al. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nat Chem Biol. 2016 Feb;12 (2) :102-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
RNF135 CRISPR Knock Out 293T Cell Line (Human)
LOC669006 Mouse siRNA Oligo Duplex (Locus ID 669006)
![BAIAP2 Mouse Monoclonal Antibody [Clone 1F4]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)